Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.

Lambert M, Schimmelmann BG, Karow A, Naber D.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S181-90. Review.

PMID:
14677077
2.

Patients' subjective experiences of antipsychotics: clinical relevance.

Hellewell JS.

CNS Drugs. 2002;16(7):457-71. Review.

PMID:
12056921
3.

Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Lambert M, Naber D.

CNS Drugs. 2004;18 Suppl 2:5-17; discussion 41-3. Review.

PMID:
15461312
4.

Subjective well-being and quality of life under atypical antipsychotic treatment.

Karow A, Naber D.

Psychopharmacology (Berl). 2002 Jun;162(1):3-10. Epub 2002 Apr 20. Review.

PMID:
12107610
5.

Good tolerability equals good results: the patient's perspective.

Naber D, Karow A.

Eur Neuropsychopharmacol. 2001 Oct;11 Suppl 4:S391-6. Review.

PMID:
11587886
6.

[The initial dysphoric reaction (IDR) to the first dose of neuroleptics].

Schimmelmann BG, Schacht M, Perro C, Lambert M.

Nervenarzt. 2004 Jan;75(1):36-43. German.

PMID:
14722660
7.

Subjective well-being under the neuroleptic treatment and its relevance for compliance.

Naber D, Karow A, Lambert M.

Acta Psychiatr Scand Suppl. 2005;(427):29-34. Review.

PMID:
15943008
9.

Neuroleptic dysphoria: towards a new synthesis.

Voruganti L, Awad AG.

Psychopharmacology (Berl). 2004 Jan;171(2):121-32. Epub 2003 Nov 27. Review.

PMID:
14647964
10.

Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome.

Awad AG, Voruganti LN, Heslegrave RJ, Hogan TP.

Int Clin Psychopharmacol. 1996 May;11 Suppl 2:55-9. Review.

PMID:
8803661
11.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Awad AG, Voruganti LN.

CNS Drugs. 2004;18(13):877-93. Review.

PMID:
15521791
12.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
13.

[Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].

Naber D, Lambert M, Karow A.

Psychiatr Prax. 2004 Nov;31 Suppl 2:S230-2. Review. German.

PMID:
15586315
15.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
16.

Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.

Löffler W, Kilian R, Toumi M, Angermeyer MC.

Pharmacopsychiatry. 2003 May;36(3):105-12.

PMID:
12806568
17.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

18.

Subjective experience and mental side-effects of antipsychotic treatment.

Gerlach J, Larsen EB.

Acta Psychiatr Scand Suppl. 1999;395:113-7.

PMID:
10225340
19.

Subjective response to neuroleptics and the quality of life: implications for treatment outcome.

Awad AG, Hogan TP.

Acta Psychiatr Scand Suppl. 1994;380:27-32. Review.

PMID:
7914044
20.

Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.

Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):755-60. doi: 10.1016/j.pnpbp.2007.12.002. Epub 2007 Dec 14.

PMID:
18226436

Supplemental Content

Support Center